
A Path to Preventing Cognitive Impairment Due to Alzheimer's Disease
16.04.2026
0:00
2:02
Dr. Greg Cooper and Dr. Eric Reiman discuss emerging antibody therapies for preclinical Alzheimer's disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.
Show citation:
Reiman EM, Alexander RC, Langbaum JB, et al. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol. 2026;25(3):268-278. doi:10.1016/S1474-4422(25)00483-1
Więcej odcinków z kanału "Neurology Minute"



Nie przegap odcinka z kanału “Neurology Minute”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








